Nigeria is expecting a cumulative of 41,282,770 vaccines through the COVAX facility and the African Union Commission by the end of September, the Federal Government has disclosed.
The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Dr Faisal Shuaib, disclosed these during a joint briefing with the World Health Organization (WHO) and the United Nations Children’s Emergency Fund (UNICEF) in Abuja.
He stated 3,924,000 doses of Oxford/AstraZeneca are expected by end of July or early August 2021 from the COVAX facility; 3,930,910 doses of Pfizer-Bio-NTech COVID-19 vaccine expected in August from the COVAX facility donated by the United States Government and 3,577,860 doses of Pfizer-Bio-NTech COVID-19 vaccine expected in the third quarter from the COVAX facility.
Furthermore, 29,850,000 doses of Johnson & Johnson (Jassen) COVID-19 vaccine are expected by the end of September, which will arrive in batches from the African Union Commission.
It reiterated that AstraZeneca vaccines being utilised in-country is effective against the Delta variant recently identified in the country.